InsiderClue
Insiders · Profile

Atlas Venture Associates IX, L.P.

10% owner at Intellia Therapeutics. Filing since 9 Mar 2017. CIK 0001671208

Company
Date
Role
Action
Shares
Amount
Of holding
NTLA Intellia Therapeutics, Inc.
10 Mar 2017
10% owner
Sold, plan not stated
5,504
$77.41K
100%
NTLA Intellia Therapeutics, Inc.
9 Mar 2017
10% owner
Sold, plan not stated
15,628
$216.43K
74.0%
2 decisions on file.